AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more
ABBV is expected to pay dividends on February 17, 2026
A dividend of $1.73 per share will be paid with a record date of February 17, 2026, and an ex-dividend date of January 16, 2026. The last dividend of $1.64 was paid on November 14. Read more...
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABBV showed earnings on October 31, 2025. You can read more about the earnings report here.